Apheresis registry in france: Indications, techniques, and complications

Therapeutic Apheresis

Volumn 4, Issue 3, 2000, Pages 207-210

  Korach, J M ^a   Guillevin, L ^b   Petitpas, D ^a   Berger, P ^a   Chillet, P ^a  

^a CENTRE HOSPITALIER   (France)

^b AVICENNE HOSPITAL   (France)

Author keywords

Complications; French registry; Indications; Plasma exchange; Techniques

Indexed keywords

CENTRIFUGATION; CONFERENCE PAPER; DATA BASE; FRANCE; INTERNET; NEUROLOGIC DISEASE; PLASMAPHERESIS; PRIORITY JOURNAL;

BLOOD COMPONENT REMOVAL; DATA COLLECTION; DATABASES, FACTUAL; FRANCE; HUMANS; INTERNATIONAL COOPERATION; INTERNET; PATIENT SELECTION; PLASMA EXCHANGE; REGISTRIES;

EID: 0033924217     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2000.00201.x     Document Type: Conference Paper

References (12)

1. Elkharrat D, Pourrat J, Gajdos Ph. Data of the French Registry for plasma exchange:1986. The French Society of Hemapheresis. Clin Apheresis 1990;5(4):527-33.
2. Elkharrat D, Bussel A, Pourrat J, Gajdos Ph. Registre National des Echanges Plasmatiques. Indications et effets secondaires en 1987 et 1988. Ann Med Interne (Paris) 1990;141(7): 586-7.
3. Bussel A, Pourrat J, Elkharrat D, Gajdos Ph. The French Registry for plasma exchange: a four year experience. Editorial, Int J Artif Org 1991;14:393-7.
4. Korach J-M, Bussel A, Annane D, Gajdos Ph. 1991 Registry of The French Society of Hemapheresis (SFH): Preliminary results for the first year of the One-line computer access file. Transfus Sci 1993;14:281-5.
5. Korach J-M, Bussel A, Dinet N. Evolution des indications et techniques des échanges plasmatiques. Les enseignements du Registre Français d'Hémaphérèse. Ann Med Interne (Paris) 1995;146, no1,13-7.
6. Guidet B, Staikowsky F, Vassal T, Offenstadt G, Amstutz P. Efficacité et tolérance de l'Elohes dans les échanges plasmatiques. Ann Fr Anesth Réanim 1992;11:534-9.
7. Le Conte P, Nicolas F, Adjou C, N'Guyen J.M, Billaud E, Moreau P. Replacement fluids in plasmapheresis: Cross-over comparative study Intensive Care Med 1997;23:342-4.
8. Korach J-M, Berger Ph, Giraud C, Le Perff Desman C, Chillet P, and the French Registry Study Group. Role of replacement fluids in the immediate complications of plasma exchange. Intensive Care Med 1998;24:452-8.
9. Raphaël JC, Chevret S, Jars-Guincestre MC, Chastang C, Gajdos Ph. Immunoglobulines ou échanges plasmatiques? Syndrome de Guillain-Barré: Indications respectives des échanges plasmatiques et des immunoglobulines. Ann Med Interne (Paris) 1993;144(8):526-31.
10. Raphaël JC, Annane D, Chevret S, Chillet P, Gajdos Ph. Indications respectives des échanges plasmatiques et de fortes doses d'immunoglobulines dans les polyradiculonévrites et la myasthénie. Presse Med 1996;19:25-31.
11. Myasthenia Gravis Clinical Study Group. Gajdos Ph, Chevret S, Clair B, Tranchant C, Chastang C. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Ann Neurol 1997;41:789-96.
12. Guillevin L, Cevallos R, Durand-Gasselin B, Lhote F, Jarrousse B, Callard P. Treatment of glomerulonephritis in microscopic polyangiitis and Churg Strauss syndrome. Indications of plasma exchanges, Metaanalysis of 2 randomized studies on 140 patients, 32 with glomerulo-nephritis. Ann Med Interne (Paris) 1997;148(3):198-204.